Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/28573357http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28573357http://www.w3.org/2000/01/rdf-schema#comment"

Background

Neuregulin 1 (NRG1), a ligand for human epidermal growth factor (HER) 3 and HER4, can activates cell signaling pathways to promote carcinogenesis and metastasis.

Methods

To investigate the clinicopathologic significance of NRG1 and its receptors, immunohistochemistry was performed for NRG1, HER3, and HER4 in 502 consecutive gastric cancers (GCs). Furthermore, HER2, microsatellite instability (MSI), and Epstein-Barr virus (EBV) status were investigated. NRG1 gene copy number (GCN) was determined by dual-color fluorescence in situ hybridization (FISH) in 388 available GCs.

Results

NRG1 overexpression was observed in 141 (28.1%) GCs and closely correlated with HER3 (P = 0.034) and HER4 (P < 0.001) expression. NRG1 overexpression was significantly associated with aggressive features, including infiltrative tumor growth, lymphovascular, and neural invasion, high pathologic stage, and poor prognosis (all P < 0.05), but not associated with EBV, MSI, or HER2 status. Multivariate analysis identified NRG1 overexpression as an independent prognostic factor for survival (P = 0.040). HER3 and HER4 expressions were observed in 157 (31.3%) and 277 (55.2%), respectively. In contrast to NRG1, expression of these proteins was not associated with survival. NRG1 GCN gain (GCN ≥ 2.5) was detected in 14.7% patients, including two cases of amplification, and was moderately correlated with NRG1 overexpression (κ, 0.459; P < 0.001).

Conclusions

Although our results indicate a lack of prognostic significance of HER3 and HER4 overexpression in GC, overexpression of their ligand, NRG1, was associated with aggressive clinical features and represented an independent unfavorable prognostic factor. Therefore, NRG1 is a potential prognostic and therapeutic biomarker in GC patients."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.org/dc/terms/identifier"doi:10.1007/s10120-017-0732-7"xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Lee K."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Lee K.S."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Lee H.S."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Park D.J."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Lee S.M."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Kim W.H."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Ahn S.H."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Koh J."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Kim H.H."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Yun S."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Park J.O."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Choe G."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/author"Nam S.K."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/name"Gastric Cancer"xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/pages"225-236"xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/title"Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients."xsd:string
http://purl.uniprot.org/citations/28573357http://purl.uniprot.org/core/volume"21"xsd:string
http://purl.uniprot.org/citations/28573357http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28573357
http://purl.uniprot.org/citations/28573357http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/28573357
http://purl.uniprot.org/uniprot/#_A0A024QY88-mappedCitation-28573357http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28573357
http://purl.uniprot.org/uniprot/#_A6MW54-mappedCitation-28573357http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/28573357
▶